AR and triple-negative breast carcinoma: Triple negative breast cancer (TNBC) is a heterogenous disease classified into major molecular subtypes [basal-like1, basal-like2, mesenchymal, and luminal androgen receptor (LAR)], each characterized by different clinicopathologic and molecular features [1].